CDX-1140 : A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies

Investigator: Maen Abdelrahim, MD

Study Coordinator: Caroline Fitzgerald

Status: Enrolling Number: NCT03329950

Phone: 713.441.3250

Protocol Number: Pro00020292


This is a study to determine the maximum tolerated dose (MTD) for CDX-1140, either alone or in combination with CDX-301, and to further evaluate its tolerability and efficacy in expansion cohorts once the MTD is determined.
More to Explore